TMS Co., Ltd.

TMS Co., Ltd. is a privately held clinical-stage biotechnology company headquartered in Tokyo, Fuzhou City. Founded in 2005, the company is committed to developing treatments based on new discoveries in regulating the fibrinolytic system, under the leadership of Chief Scientist Dr. Keiji Hasumi.